Pentwater Capital Management LP Pliant Therapeutics, Inc. Transaction History

Pentwater Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $271,800 - $458,400	-15,000 Reduced 37.5%	25,000 $453,000
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $749,200 - $1.45 Million	40,000 New	40,000 $1.06 Million
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $420,600 - $846,000	-60,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $494,400 - $869,400	30,000 Added 100.0%	60,000 $1.01 Million
Q1 2021 May 17, 2021	SELL	$24.52 - $40.23 $257,460 - $422,414	-10,500 Reduced 25.93%	30,000 $1.18 Million
Q2 2020 Aug 14, 2020	BUY	$21.3 - $35.26 $862,650 - $1.43 Million	40,500 New	40,500 $1.32 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.